Table 3.
Comparison of HIF-1α Protein Expression With Other Biomarkers in R-CHOP-Treated Patients (n = 78)
Biomarker | HIF-1α Expression |
P† | |
---|---|---|---|
Positive | Negative | ||
BCL2* | |||
Positive | 32 | 21 | .54 |
Negative | 16 | 8 | |
CD10 | |||
Positive | 18 | 12 | .81 |
Negative | 31 | 17 | |
MUM-1* | |||
Positive | 34 | 16 | .24 |
Negative | 15 | 12 | |
BCL6* | |||
Positive | 45 | 19 | .004 |
Negative | 3 | 10 | |
FOXP1 | |||
Positive | 14 | 10 | .59 |
Negative | 35 | 19 |
Abbreviations: HIF, hypoxia-inducible factor; R-CHOP, rituximab with cyclophosphamide, doxorubicin, oncovin, and prednisone.
One sample in each group could not be scored.
Two-sided P value.